Adage Capital Updates Wave Life Sciences Stake

TL;DR

**Adage Capital just updated its stake in Wave Life Sciences.**

AI Summary

Adage Capital Partners GP, L.L.C. filed an amended Schedule 13G/A on February 7, 2024, indicating a change in their ownership of Wave Life Sciences Ltd. ordinary shares as of December 31, 2023. This filing updates their previous disclosure, showing their current stake in the pharmaceutical company. This matters to investors because it reveals a significant institutional investor's updated position, which can influence market perception and potentially signal their confidence (or lack thereof) in the stock's future performance.

Why It Matters

This filing shows an institutional investor's updated position in Wave Life Sciences, which can signal their confidence in the company's future and influence other investors.

Risk Assessment

Risk Level: low — This filing is a routine update from an institutional investor and does not inherently signal high risk.

Analyst Insight

Investors should monitor subsequent filings from Adage Capital Partners GP, L.L.C. to understand if their stake in Wave Life Sciences Ltd. is increasing or decreasing, as this could indicate their long-term view on the company's prospects.

Key Players & Entities

• Adage Capital Partners GP, L.L.C. (company) — the reporting person filing the SC 13G/A
• Wave Life Sciences Ltd. (company) — the issuer of the securities
• December 31, 2023 (date) — the date of the event requiring the filing
• February 7, 2024 (date) — the filing date of the SC 13G/A

FAQ

Filing Documents

• p24-0577sc13ga.htm (SC 13G/A) — 95KB
• 0000902664-24-001195.txt ( ) — 96KB

(a)

Item 1(a). NAME OF ISSUER The name of the issuer is Wave Life Sciences Ltd. (the “ Company ”).

(b)

Item 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES The Company’s principal executive offices are located at 7 Straits View #12-00, Marina One, East Tower, Singapore 018936.

(a)

Item 2(a). NAME OF PERSON FILING This statement is filed by: (i) Adage Capital Partners, L.P., a Delaware limited partnership (“ ACP ”) with respect to the Ordinary Shares directly owned by it; (ii) Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware (“ ACPGP ”), as general partner of ACP with respect to the Ordinary Shares directly owned by ACP; (iii) Adage Capital Management, L.P., a Delaware limited partnership (“ ACM ”), as the investment manager of ACP, with respect to the Ordinary Shares directly owned by ACP; (iv) Robert Atchinson (“ Mr. Atchinson ”), as (1) managing member of Adage Capital Advisors, L.L.C., a limited liability company organized under the laws of the State of Delaware (“ ACA ”), managing member of ACPGP and (2) managing member of Adage Capital Partners LLC, a Delaware limited liability company (“ ACPLLC ”), general partner of ACM, with respect to the Ordinary Shares directly owned by ACP; and (v) Phillip Gross (“ Mr. Gross ”), as (1) managing member of ACA, managing member of ACPGP and (2) managing member of ACPLLC, general partner of ACM, with respect to the Ordinary Shares directly owned by ACP. The foregoing persons are hereinafter sometimes collectively referred to as the “ Reporting Persons .” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE The address of the business office of each of the Reporting Persons is 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116.

(c)

Item 2(c). CITIZENSHIP ACP and ACM are limited partnerships organized under the laws of the State of Delaware. ACPGP is a limited liability company organized under the laws of the State of Delaware. Messrs. Gross and Atchinson are citizens of the United States.

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES Ordinary Shares, no par value (the “ Ordinary Shares ”). CUSIP No. Y95308105 13G/A Page 8 of 10 Pages

(e)

Item 2(e). CUSIP NUMBER Y95308105 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under Section 15 of the Act; (b) Bank as defined in Section 3(a)(6) of the Act; (c) Insurance company as defined in Section 3(a)(19) of the Act; (d) Investment company registered under Section 8 of the Investment Company Act of 1940; (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Not applicable . Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in this Schedule 13G/A is calculated based upon 119,011,901 Ordinary Shares reported to be outstanding in the Company’s Prospectus filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on December 8, 2023, and in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 4, 2024, after giving effect to the completion of the offering, as described therein. Item 5. Not applicable. Item 6.

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: February 7, 2024 ADAGE CAPITAL PARTNERS, L.P. By: Adage Capital Partners GP, L.L.C., its general partner By: Adage Capital Advisors, L.L.C., its managing member /s/ Robert Atchinson Name: Robert Atchinson Title: Managing Member ADAGE CAPITAL PARTNERS GP, L.L.C. By: Adage Capital Advisors, L.L.C., its managing member /s/ Robert Atchinson Name: Robert Atchinson Title: Managing Member ADAGE CAPITAL MANAGEMENT, L.P. By: Adage Capital Partners LLC, its general partner /s/ Robert Atchinson Name: Robert Atchinson Title: Managing Member /s/ Robert Atchinson ROBERT ATCHINSON, individually /s/ Phillip Gross PHILLIP GROSS, individually

View Full Filing

View this SC 13G/A filing on SEC EDGAR